Table 1.

Characteristics of the cohort of patients in this study.

Patient	Dx	VL	CD4 (cells/μl)	CD4 Nadir (cells/μl)	Gender	Age	AChE units
1	HAD	U	496	434	M	68.9	1064
2	HAD	U	330	200	M	56.7	1177
3	HAD	U	428	320	M	52.8	1078
4	HAD	U	110	150	M	54	1152
5	HAD	U	325	220	M	57.9	944
6	HAD	U	186	200	M	57	1218
7	HAD	U	415	300	M	59.5	1181
8	HAD	U	512	370	M	54.3	1182
9	HAD	U	424	280	M	52.6	1212
10	HAD	U	565	585	M	53.8	1073
11	HAD	U	525	460	F	52	1199
12	HAD	U	146	52	M	73.7	805
13	NC	U	541	300	M	54.5	922
14	NC	U	588	350	M	58.5	333
15	NC	U	662	653	M	54.1	420
16	NC	U	718	485	M	56.7	195
17	NC	U	1023	869	F	40.4	567
18	NC	U	740	697	M	55	786
19	NC	U	521	323	M	33.9	608
20	NC	U	254	229	M	39.7	536
21	NC	U	744	744	M	42.7	611

HAD HIV-associated dementia, NC Normal cognition, VL viral load, U Undetectable HIV RNA level, AChE acetylcholinesterase, M Male, F Female